G6PD
MOLECULAR TARGETglucose-6-phosphate dehydrogenase
G6PD (glucose-6-phosphate dehydrogenase) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting G6PD
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | prasterone | 3.58 | 35 |
| 2 | wedelolactone | 3.00 | 19 |
| 3 | Dehydroepiandrosterone | 1.10 | 2 |
| 4 | Dehydroepiandrosterone | 1.10 | 2 |
About G6PD as a Drug Target
G6PD (glucose-6-phosphate dehydrogenase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented G6PD interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
G6PD inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.